Hyphens Pharma

Hyphens’ 9MFY2020 earnings came 17% below the analyst's estimates due to other losses arising from inventory obsolescence.

Derek Goh, executive chairman of Serial Systems, bought 1.5 million shares on the open market for $106,500 on June 2, which works out to an average of 7.1 cents per share. A day earlier and on May 4, Goh had acquired 5.2 million shares for $365,144 and 12

“COVID-19 has created a challenging operating environment, however, we remain agile and to adapt to a different operating environment,” says Hyphens Pharma’s executive chairman & CEO Lim See Wah

Group revenue for the quarter fell 6.1% to $29 million from $30.9 million the preceding year,  due primarily to a decline of 14.1% in the specialty pharma principals segment in 2Q19 on the back of higher demand in 2Q18, ahead of products licensing renewa

SINGAPORE (June 18): Hyphens Pharma has launched in Vietnam the Magnezix brand of implants by Syntellix AG.

SINGAPORE (May 29): Healthcare veteran Lim See Wah's rejection from medical school more than three decades ago turned out to be a significant pivot in his entrepreneurial journey.